Motixafortide

Purogiramu inonzi Motixafortide

Motixafortide inogadzirwa neCXCR4 antagonist peptide yakagadziridzwa kuunganidza hematopoietic stem masero (HSCs) e autologous transplantation uye zvakare iri kudzidzwa mune oncology uye immunotherapy.

Mechanism & Tsvagiridzo:

Motixafortide inovhara iyo CXCR4-SDF-1 axis, inotungamira ku:
Rapid stem cell mobilization muropa reperipheral
Kuwedzerwa immune cell kutengesa uye kupinza bundu
Inogona synergy ine checkpoint inhibitors uye chemotherapy

Yakaratidza hukuru hwe stem cell goho kana ichienzaniswa nevekukurudzira varipo mumakiriniki ekuedzwa.
API Zvimiro (Gentolex Boka):

High-purity synthetic peptide
GMP-yakafanana yekugadzira zviyero
Inokodzera kugadzirwa kwejekiseni

Motixafortide API inotsigira tsvakiridzo yepamusoro mu stem cell therapy uye cancer immunotherapy.